A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations - Jing Ma; Xuelu Li; Qianran Zhang; Ning Li; Siwen Sun; Shanshan Zhao; Zuowei Zhao; Man Li (Translational Oncology, 2022)